FDA Classifies Transcutaneous Electrical Nerve Stimulator for Fibromyalgia Symptoms into Class II

The Food and Drug Administration (FDA) has classified the transcutaneous electrical nerve stimulator (TENS) to treat fibromyalgia symptoms into Class II, with special controls. This action is intended to provide reasonable assurance of the device's safety and effectiveness and enhance patient access to beneficial innovative devices by reducing regulatory burdens.